Bioqual (OTCMKTS:BIOQ) Posts Earnings Results

Bioqual (OTCMKTS:BIOQ) issued its quarterly earnings data on Tuesday. The company reported ($1.36) earnings per share (EPS) for the quarter, Zacks reports. Bioqual had a negative return on equity of 2.87% and a negative net margin of 1.99%.

Bioqual Stock Performance

Shares of BIOQ remained flat at $65.00 during mid-day trading on Tuesday. Bioqual has a one year low of $65.00 and a one year high of $80.00. The company has a market capitalization of $57.85 million, a P/E ratio of -52.85 and a beta of -0.33. The stock has a 50-day simple moving average of $66.56 and a two-hundred day simple moving average of $68.52.

Bioqual Company Profile

Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.